Aurobindo Pharma US FDA Completes Inspection of APL Healthcare Unit-IV
The United States Food and Drug Administration (US FDA) concluded its inspection of Aurobindo Pharma’s Unit-IV of APL Healthcare Limited…
Sun Pharmaceutical US FDA Classifies Baska Facility Inspection as OAI
The US FDA has classified the inspection of Sun Pharmaceutical’s Baska facility as Official Action Indicated (OAI). The inspection was…
ACME Solar Secures INR 4,725 Crore Financing to Expand Operations
ACME Solar Holdings Ltd has secured INR 4,725 crore in debt financing from leading Indian financial institutions. The funds will support the…
Indian Overseas Bank Government Exercises Oversubscription Option for Equity Sale
The President of India, acting through the Department of Financial Services, has exercised the oversubscription option for the sale of Indian…
One 97 Communications Paytm Receives RBI Authorization for Offline & Cross-Border Payments
Paytm Payments Services Limited (PPSL), a wholly-owned subsidiary of One 97 Communications, has received authorization from the Reserve Bank…
AstraZeneca Receives Approval for Datopotamab Deruxtecan in India
AstraZeneca Pharma India has secured approval to import and distribute Datopotamab Deruxtecan in India. This new drug is a concentrate for…
Adani Enterprises Rights Issue Committee Sets Record Date for First Call
The Rights Issue Committee of Adani Enterprises has set December 23, 2025, as the record date for determining shareholders eligible for the…
Adani Enterprises Rights Issue Committee Sets Record Date for First Call
The Rights Issue Committee of Adani Enterprises has set December 23, 2025, as the Record Date for determining eligible shareholders for the…
Vedanta Hindustan Zinc Faces Penalty from Corporate Affairs Ministry
Hindustan Zinc Limited (HZL), a subsidiary of Vedanta, has received a penalty from the Ministry of Corporate Affairs. The penalty was levied…
IIFL Finance Board to Consider Issuance of Non-Convertible Debentures
The Board of Directors of IIFL Finance is scheduled to meet on December 22, 2025, to consider and approve terms & conditions for the…